Alan Brochstein

These Cannabis ETFs Fall Short Amidst S&P/TSX Discontinuation: What Investors Need To Know
Michigan Marijuana Sales Rise 9% To $221.7 Million In December, Expert Says
Cannabis Sales Update: October Was Weak Overall, But Not In Florida
Michigan Marijuana Sales Rise 9% To $221.7 Million In December, Expert Says
Cannabis Sales Update: October Was Weak Overall, But Not In Florida
Michigan Report: Cannabis Regulatory Agency Recalls Products, October Sales Decrease
Is The Cannabis Market Stagnating In Canada? Sales Show Slowest Annual Growth To Date In August

Alan Brochstein Recent News

Global Cannabis Stock Index Meltdown in September, 'Didn't Matter Much,' Expert Says
In September, the Global Cannabis Stock Index closed low on 9/30 and ended the month down 25.9%, wrote Ala
Canadian Cannabis Sales Continued To Increase In July, Here's Why
Recently, Statistics Canada released July retail cannabis sales for the country. The reports showed that marijuana sales increased from June by 4.5% to C$394.8M.
What's Going On With Cannabis Stocks And Markets? Follow These Top Finance Reporters To Stay Ahead Of Trends
Who are the most experienced and engaged cannabis finance reports? Let's find out. After the overwhelming success of Benzinga's 4/20 Miami event, the Benzinga Cannabis Capital Conference is returning to Chicago on September 13-14.
These 7 Cannabis Stocks May Be Underappreciated As Market Continues To Rebound
Michigan Cannabis Sales Boom Again To $154M After Slow January
Following a January dip shall we call it, Michigan's cannabis sales rebounded nicely in February, gaining in total 1.59% to $154.8 million - up 47% from a year ago. 
Pricing Pressure, Illegal Cannabis Products – Curaleaf And GTI Explain Impacts On Their Earnings
Cannabis earnings season took off last week mostly to the delight of many marijuana-focused investors when reports from two large multi-state operators – Curaleaf (OTCQX: CURLF) and Green Thumb Industries (OTCQX:
Global Cannabis Stock Index Falls, Nearly But Not Quite Breaking 11-Month Losing Streak
The Global Cannabis Stock Index fell for the 12th consecutive month, declining 1.1% to 28.31, reported Alan Brochstein, founder of New Cannabis Ventures and 420 Investor.
Aurora Cannabis Is Selling Stock To Pay Off Debt: Why Tilray And Canopy Could Be Next In Line
Earlier this month, Aurora Cannabis (NASDAQ: ABC) reported its second-quarter financial results, revealing a 10% decline in total net revenue, which totaled slig
Cannabis Stocks Are Among Best Performers In 2022 As Earnings Season Nears
After a rough start in 2022, cannabis stocks seem to have bounced back quickly to become the best performers year-to-date, outpacing the broader stock market or other high-risk sectors.
420 Investor: "This Is The Most Excited I've Ever Been" In Cannabis
Alan Brochstein, author of 420 Investor and founding partner of New Cannabis Ventures, says the recent political momentum behind the cannabis legalization push in the US — and the resulting rebound in cannabis stocks since the U.S. election — has him feeling extremely optimistic about the industry's future.
Here's Why Cannabis Stocks Are Getting A Boost
Several cannabis companies such as Canopy Growth Corp. (NYSE: CGC), Tilray Inc. (NASDAQ: TLRY) and Aurora Cannabis Inc. (NYSE: ACB)
Cannabis Analysts From Piper Sandler, Jefferies, Cowen On Their Favorite Companies, Investments
Some of the most high-profile cannabis analysts shared their insights in a thrilling discussion about trends, strategies and forecasts at the Virtual Benzinga Cannabis Capital Conference. Alan Brochstein, the founder of 420 Investor and New Cannabis Ventures, led the discussion.
Aurora Cannabis Shares Rise 50% On Sales Beat: 'A Case Of The Patient Being Presumed Dead, When Indeed It's Not'
Aurora Cannabis Inc (NYSE: ACB)(TSE:ACB) reported a 35% sequential sales increase for the third quarter to far exceed analyst expectations.
How Legalizing Marijuana Could Help Kick-Start The US Economy
As shelter-in-place orders drag on and the U.S. economy limps through the second quarter, investors, economists and politicians are asking important questions about what the post-outbreak economy will look like and how quickly the U.S. can replace the 26 million jobs it has lost in 2020.
Why Tilray, Canopy Growth And Other Cannabis Stocks Are Rallying Today
Big cannabis stocks are rallying on Monday, with many posting double-digits gains. So what’s going on? Alan Brochstein, author of the 420 Investor and founder of New Cannabis Ventures, said the move "seems driven by Canadian LPs, and some of that may be short-covering."
How The Impending Recession Could Change The Cannabis Industry: 'Everybody Is Going To Raise Capital'
Alan Brochstein, founder of 420 Investor and New Cannabis Ventures, joined Benzinga’s PreMarket Prep show Monday to discuss how the cannabis industry and its main players are navigating the looming recession.
These 4 Cannabis Stocks Are The Safest Bets Right Now, Expert Says
It has been a brutal couple of years for cannabis investors. With most leading stocks down even further since the COVID-19 outbreak, cannabis investors are now weighing whether to cut their losses or buy the dip in a bet on a rebound ahead.
Why Tilray's Stock Is Trading Higher Today
More Consolidation In The Brokerage Space: PreMarket Prep Recap For Feb. 20, 2020
Will Cannabis Stocks Bounce Back In 2020?
Canada Sold $1.1B Of Legal Cannabis In First Year; Black Market Still Dominates
One Year Later: How Every Major Cannabis Stock Has Performed Since Canadian Legalization
PreMarket Prep Recap: Market-Moving News On Columbus Day